• 1
    Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American college of chest physicians/society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864874.
  • 2
    Ziegler EJ. Protective antibody to endotoxin core: the emperor's new clothes. J Infect Dis 1988; 158: 286290.
  • 3
    Parrillo JE, Parker MM, Natanson C, Suffredini AF, Banner RL, Cunnion RE, Ognibene FP. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113: 227242.
  • 4
    Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH. et al. Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991; 324: 429436.
  • 5
    Exley AR, Cohen J, Buurman W, Owen R, Hanson G, Lumley J, Aulakh JM. et al. Monoclonal antibody to TNF in severe septic shock. Lancet 1990; 335: 12751277.
  • 6
    Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348: 550552.
  • 7
    Galanos C, Freudenberg MA, Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76: 59395943.
  • 8
    Utili R, Abernathy CO, Zimmerman HJ. Minireview: endotoxin effects on the liver. Life Sci 1977; 20: 553568.
  • 9
    Doi F, Goya T, Torisu M. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis. Hepatology 1993; 17: 10861094.
  • 10
    Keller GA, West MA, Cerra FB, Simmons RL. Multiple systems organ failure: modulation of hepatocyte protein synthesis by endotoxin activated kupffer cells. Ann Surg 1985; 201: 8795.
  • 11
    Stadler J, Bentz BG, Harbrecht BG, Silvio MD, Curran RD, Billiar TR, Hoffman RA. et al. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. Ann Surg 1992; 216: 539546.
  • 12
    McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B. In vivo microscopic studies of the responses of the liver to endotoxin. Klin Wochenschr 1982; 60: 749751.
  • 13
    Meyer RA, Sweeney HL, Kushmerick MJ. A simple analysis of the “phosphocreatine shuttle.” Am J Physiol 1984; 246: 0365377.
  • 14
    Miller K, Halow J, Koretsky AP. Phosphocreatine protects transgenic mouse liver expressing creatine kinase from hypoxia and ischemia. Am J Physiol 1993; 265: C15441551.
  • 15
    Koretsky AP, Brosnan MJ, Chen L, Chen J, Van Dyke T. NMR detection of creatine kinase expressed in liver of transgenic mice: determination of free ADP levels. Proc Natl Acad Sci U S A 1990; 87: 31123116.
  • 16
    Walker JB. Creatine: biosynthesis, regulation, and function. Adv Enzymol Relat Areas Mol Biol 1979; 50: 177242.
  • 17
    Veech RL, Guynn R, Veloso D. The time-course of the effects of ethanol on the redox and phosphorylation states of rat liver. Biochem J 1972; 127: 387397.
  • 18
    Sellevold OFM, Jynge P, Aarstad K. High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol 1986; 18: 517527.
  • 19
    Atkinson DE, Walton GM. Adenosine triphosphate conservation in metabolic regulation: rat liver citrate cleavage enzyme. J Biol Chem 1967; 242: 32393241.
  • 20
    Lawson JWR, Veech RL. Effects of pH and free Mg2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 1979; 254: 65286537.
  • 21
    Veech RL, Lawson JWR, Cornell NW, Krebs HA. Cytosolic phosphorylation potential. J Biol Chem 1979; 254: 65386547.
  • 22
    Ozawa K, Kitamura O, Mizukami T, Yamaoka Y, Kamano T, Takeda H, Takasan H. et al. Human liver mitochondria. Clin Chim Acta 1972; 38: 385393.
  • 23
    Inomoto T, Tanaka A, Mori S, Jin MB, Sato B, Yanabu N, Tokuka A. et al. Changes in the distribution of the control of the mitochondrial oxidative phosphorylation in regenerating rabbit liver. Biochim Biophys Acta 1994; 1188: 311317.
  • 24
    Tanaka A, Feng Z, Inomoto T, Mori S, Tokuka A, Shinohara H, Kataoka M. et al. Kinetic analysis of impaired work-cost performance in jaundiced rabbit liver. Res Exp Med 1995; 195: 7784.
  • 25
    Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. J Biol Chem 1955; 217: 383393.
  • 26
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248254.
  • 27
    Jöbsis FF. Oxidative metabolism at low PO2. Fed Proc 1972; 31: 14041413.
  • 28
    Hatefi Y, Stiggall DL. Metal-containing flavoprotein dehydrogenases. In: BoyerPD. ed. The enzymes. New York: Academic, 1976: 177221.
  • 29
    Ikeda T, Hirata K, Tabuchi K, Tamura H, Tanaka S. Quantitative measurement of endotoxin in canine plasma using the new endotoxin-specific chromogenic test. Circ Shock 1987; 23: 263269.
  • 30
    Litchfield Jr JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol 1949; 96: 99113.
  • 31
    Yan C, Costa RH, Darnell JE Jr, Chen J, Van Dyke TA. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 1990; 9: 869878.
  • 32
    Brosnan MJ, Chen L, Van Dyke TA, Koretsky AP. Free ADP levels in transgenic mouse liver expressing creatine kinase: effects of enzyme activity, phosphagen type, and substrate concentration. Biol Chem 1990; 265: 2084920855.
  • 33
    Shimahara Y, Ozawa K, Ida T, Ukikusa M, Tobe T. Role of mitochondrial enhancement in maintaining hepatic energy charge level in endotoxin shock. J Surg Res 1982; 33: 314323.
  • 34
    Mizock B. Septic shock: a metabolic perspective. Arch Intern Med 1984; 144: 579585.
  • 35
    Atkinson DE. Cellular Energy Metabolism and Its Regulation. New York: Academic, 1977.
  • 36
    Kennedy BG, Lunn G, Hoffman JF. Effects of altering the ATP/ADP ratio on pump-mediated Na/K and Na/Na exchanges in resealed human red blood cell ghosts. J Gen Physiol 1986; 87: 4772.
  • 37
    Tanaka A, Chance B, Quistorff B. A possible role of inorganic phosphate as a regulator of oxidative phosphorylation in combined urea synthesis and gluconeogenesis in perfused rat liver: a phosphorus magnetic resonance spectroscopy study. J Biol Chem 1989; 264: 1003410040.
  • 38
    Chance B, Leigh JS, Clark BJ, Maris J, Kent J, Nioka S, Smith D. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A 1985; 82: 83848388.
  • 39
    Chance B, Leigh JS, Kent J, McCully K, Nioka S, Clark BJ, Maris JM. et al. Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance. Proc Natl Acad Sci U S A 1986; 83: 94589462.
  • 40
    Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992; 281: 2140.
  • 41
    Iwata S, Chance B. Effect of phosphocreatine upon gluconeogenesis in creatine kinase transfected mouse liver [Abstract]. Proceedings of the Soc Mag Reson Med 1993; 2: 1047A.
  • 42
    Mathison JC, Ulevitch RJ. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979; 123: 21332143.
  • 43
    Shimahara Y, Kiuchi T, Ozawa K, Isselhard W. Influence of colloidal carbon phagocytosis as a metabolic load on the hepatic energy metabolism in rats. J Surg Res 1990; 49: 146152.
  • 44
    Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocytes in direct of lipopolysaccharide in rats. Gastroenterology 1995; 109: 19691976.
  • 45
    Holtmann H, Wallach D. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4/? phorbol-12-myristate-13-acetate. J Immunol 1987; 139: 11611167.
  • 46
    Scheurich P, Kobrich G, Pfizenmaier K. Antagonistic control of tumor necrosis factor receptors by protein kinases A and C; enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C. J Exp Med 1989; 170: 947958.
  • 47
    Sánchez-Alcázar JA, Hernández I, De la Torre MP, Garcia I, Santiago E, Muñoz-Yagüe MT, Solis-Herruzo JA. Down-regulation of tumor necrosis factor receptors by blockade of mitochondrial respiration. J Biol Chem 1995; 270: 2394423950.
  • 48
    Xia D, Lin J, Yun T, Wagner T, Magnuson T, Samols D. Transgenic mice expressing rabbit C-reactive protein (CRP) resist endotoxemia [Abstract]. FASEB J 1991; 5: 1628.
  • 49
    Bahrami S, Redel H, Leichtfried G, Yu Y, Schlag G. Similar cytokine but different coagulation responses to lipopolysaccharide injection in D-galactosamine-sensitized versus nonsensitized rats. Infect Immun 1994; 62: 99105.
  • 50
    Bucklin SE, Silverstein R, Morrison DC. An Interleukin-6-induced acute phase response does not confer protection against lipopolysaccharide lethality. Infect Immun 1993; 61: 31843189.
  • 51
    Miyata T, Yokoyama I, Todo S, Tzakis A, Selby R, Starzl TE. Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989; 189191.
  • 52
    Yokoyama I, Todo S, Miyata T, Selby R, Tzakis AG, Starzl TE. Endotoxemia and human transplantation. Transplant Proc 1989; 21: 38333841.
  • 53
    Shaked A, Csete ME, Drazan KE, Bullington D, Wu L, Busuttil RW, Berk AJ. Adenovirus-mediated gene transfer in the transplant setting. Transplantation 1994; 57: 15081511.